• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

W. S. McDougal, MD


  • Eswara JR, Heney NM, Wu CL, McDougal WS.
    Long-Term Outcomes of Organ Preservation in Patients with Small Cell Carcinoma of the Bladder.
    Urol. Int. 2015 Jan 30.
  • Talab SS, McDougal WS, Wu CL, Tabatabaei S.
    Mucosa-sparing, KTP Laser Coagulation of Submucosal Telangiectatic Vessels in Patients With Radiation-induced Cystitis: A Novel Approach.
    Urology. 2014 Jun 12.
  • Sharron Lin X, Hu L, Sandy K, Correll M, Quackenbush J, Wu CL, Scott McDougal W.
    Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: Applying RNA-sequencing analysis on archived specimens.
    Urol Oncol. 2014 Apr;32(3):327-36.
  • McDougal WS, Lee RJ, Efstathiou JA, Harisinghani M, Wu CL.
    Case records of the Massachusetts General Hospital. Case 2-2014. A 44-year-old man with a lesion on the penis.
    N Engl J Med. 2014 Jan 16;370(3):263-71.
  • Dong F, Yang P, Wang C, Wu S, Xiao Y, McDougal WS, Young RH, Wu CL.
    Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.
    Am J Surg Pathol. 2013 Dec;37(12):1855-61.
  • Eswara JR, McDougal WS.
    Long-term outcomes of surgical management for nonmalignant perineal disease.
    J Urol. 2013 Dec;190(6):2139-43.
  • Hegarty PK, Eardley I, Heidenreich A, McDougal WS, Minhas S, Spiess PE, Watkin N, Horenblas S.
    Penile Cancer: Organ-sparing techniques.
    BJU Int. 2013 Jul 1.
  • Cai C, Zhong WD, McDougal WS, Wu CL.
    A 32-gene risk index: a new prognostic approach for prostate cancer progression.
    Asian J. Androl. 2013 Sep;15(5):590-1.
  • Chekaluk Y, Wu CL, Rosenberg J, Riester M, Dai Q, Lin S, Guo Y, McDougal WS, Kwiatkowski DJ.
    Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.
    PLoS ONE. 2013;8(4):e60927.
  • Wu CL, Schroeder BE, Ma XJ, Cutie CJ, Wu S, Salunga R, Zhang Y, Kattan MW, Schnabel CA, Erlander MG, McDougal WS.
    Development and validation of a 32-gene prognostic index for prostate cancer progression.
    Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6121-6.
  • Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA.
    Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Eur Urol. 2013 Mar;63(3):486-92.
  • Lu J, Wirth GJ, Wu S, Chen J, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL.
    A close surgical margin after radical prostatectomy is an independent predictor of recurrence.
    J Urol. 2012 Jul;188(1):91-7.
  • Psutka SP, Feldman AS, Rodin D, Olumi AF, Wu CL, McDougal WS.
    Men With Organ-confined Prostate Cancer and Positive Surgical Margins Develop Biochemical Failure at a Similar Rate to Men With Extracapsular Extension.
    Urology. 2011 Mar 14.
  • Kaul D, Wu CL, Adkins CB, Jordan KW, Defeo EM, Habbel P, Peterson RT, McDougal WS, Pohl U, Cheng LL.
    Assessing prostate cancer growth with mRNA of spermine metabolic enzymes.
    Cancer Biol Ther. 2010 May;9(9):736-42.
  • Maxeiner A, Adkins CB, Zhang Y, Taupitz M, Halpern EF, McDougal WS, Wu CL, Cheng LL.
    Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles.
    Prostate. 2010 May 15;70(7):710-7.
  • Wu CL, Jordan KW, Ratai EM, Sheng J, Adkins CB, Defeo EM, Jenkins BG, Ying L, McDougal WS, Cheng LL.
    Metabolomic imaging for human prostate cancer detection.
    Sci Transl Med. 2010 Jan 27;2(16):16ra8.
  • McDougal WS.
    Editorial comment.
    J Urol. 2010 Mar;183(3):902; discussion 902.
  • McDougal WS.
    Editorial comment.
    J Urol. 2010 Jan;183(1):55.
  • Kaufman DS, McDougal WS, Harisinghani MG, Wu CL.
    Case records of the Massachusetts General Hospital. Case 30-2009. A 77-year-old man with recurrent transitional-cell carcinoma of the ureter.
    N Engl J Med. 2009 Sep 24;361(13):1292-9.
  • McDougal WS.
    Editorial comment.
    J Urol. 2009 Oct;182(4):1293; discussion 1293.
  • Dahl DM, Barry MJ, McGovern FJ, Chang Y, Walker-Corkery E, McDougal WS.
    A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy.
    J Urol. 2009 Sep;182(3):956-65.
  • Feldman AS,Banyard J,Wu CL,McDougal WS,Zetter BR.
    Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression.
    Clin Cancer Res. 2009 Feb 1;15(3):1024-31.
  • Connolly SS, Yoo JJ, Abouheba M, Soker S, McDougal WS, Atala A.
    Cavernous nerve regeneration using acellular nerve grafts.
    World J Urol. 2008 Aug;26(4):333-9.
  • Zhang H,Zhang Y,Duan HO,Kirley SD,Lin SX,McDougal WS,Xiao H,Wu CL.
    TIP30 is associated with progression and metastasis of prostate cancer.
    Int J Cancer. 2008 Aug 15;123(4):810-6.
  • Guimaraes AR, Tabatabei S, Dahl D, McDougal WS, Weissleder R, Harisinghani MG.
    Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer.
    Urology. 2008 Apr;71(4):708-12.
  • Feldman AS, McDougal WS, Harisinghani MG.
    The potential of nanoparticle-enhanced imaging.
    Urol Oncol. 2008 Jan-Feb;26(1):65-73. Review.
  • Kaufman DS, McDougal WS, Zietman AL, Young RH.
    Case records of the Massachusetts General Hospital. Case 18-2007. A 54-year-old man with early-stage prostate cancer.
    N Engl J Med. 2007 Jun 14;356(24):2515-20.
  • Dahl DM, He W, Lazarus R, McDougal WS, Wu CL.
    Pathologic outcome of laparoscopic and open radical prostatectomy.
    Urology. 2006 Dec;68(6):1253-6.
  • McDougal WS, Tolkoff-Rubin NE, Michaelson MD, Mueller PR, Braaten K.
    Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys.
    N Engl J Med. 2006 Sep 14;355(11):1161-7.
  • Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR.
    Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.
    AJR Am J Roentgenol. 2005 Jul;185(1):72-80.
  • Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR.
    Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.
    AJR Am J Roentgenol. 2005 Jul;185(1):64-71.
  • Kalish LA, McDougal WS, McKinlay JB.
    Family history and the risk of prostate cancer.
    Urology. 2000 Nov 1;56(5):803-6.
  • Planz B, Aretz HT, Wang Q, Tabatabaei S, Kirley SD, Lin CW, McDougal WS.
    Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor.
    Prostate. 1999 Dec 1;41(4):233-42.
  • Grocela JA, McDougal WS.
    Ammonium transport in the intestine chronically exposed to urine: is it reduced over time?.
    Urology. 1999 Aug;54(2):373-6.
  • Planz B, Kirley SD, Wang Q, Tabatabaei S, Aretz HT, McDougal WS.
    Characterization of a stromal cell model of the human benign and malignant prostate from explant culture.
    J Urol. 1999 Apr;161(4):1329-36.
  • Stampfer DS, McDougal WS.
    Inhibition of the sodium/hydrogen antiport by ammonium ion.
    J Urol. 1997 Jan;157(1):362-5.